v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY TO KNOW THE PREVALENCE OF RETINOPATHY AMONG PATIENTS OF TYPE II DIABETES MELLITUS

AUTHORS:

Dr Hafiza Asma Riasat Ali, Dr Dania Aijaz, Dr Mansoor Ul Hassan Qureshi

ABSTRACT:

Background: Diabetic retinopathy is the most common complication for each of us and is the foremost source of blindness globally. Diabetic nephropathy is estimated based on the presence of microalbuminuria. Its association with retinopathy is well known in patients of type I diabetes mellitus, but still uncertain in type 2 diabetes. In this study, the incidence of retinopathy was determined in type 2 diabetic patients with and without microalbuminuria. Place and Duration: In the Endocrinology department and Eye Unit I of Mayo Hospital Lahore for one year duration from April 2019 to April 2020. Study design: A cross-sectional study. Methods: 280 type II diabetes mellitus patients were selected from the Diabetes Management Center. Their spot urine microalbuminuria was performed and selectees were alienated into two groups depending on the absence or presence of microalbuminuria. Patients with macroalbuminuria and hypertension are already excluded from the study. All patients underwent retinoscopy and the frequency of microalbuminuria and retinopathy was determined. Results: The age range was 35 to 70 years. 42.5% are men and 57.5% are women. Microalbuminuria was noted in 76(27.1%) of 280 patients with diabetes. The incidence of retinopathy was advanced in subjects with microalbuminuria (44.74%), while it was 23.04% in patients without microalbuminuria. Conclusion: The occurrence of retinopathy increases in the presence of microalbuminuria. No statistically significant relationship was found in this study. Key words: microalbuminuria, diabetic nephropathy, diabetic retinopathy.

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.